Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Impulse magnetic-field therapy for erectile dysfunction: A double-blind, placebo-controlled study


This double-blind, placebo-controlled study assessed the efficacy of 3 weeks of impulse magnetic-field therapy for erectile dysfunction (ED). Twenty volunteers who suffered from ED or orgasmic disturbances were randomly assigned to either active treatment or placebo (n = 10 each). Efficacy was assessed in terms of intensity and duration of erection, general well-being, sexual activity, and warm sensation in the genital area. In the active-treatment group, all efficacy endpoints were significantly improved at study end (P=.01), with 80% reporting increases in intensity and duration of erection, frequency of genital warmth, and general wellbeing. The remaining 20%, who experienced minor improvements, were found to have an influenza-like infection after the study that may have influenced their results. Only 30% of the placebo group noted some improvement in their sexual activity; 70% had no change. No side effects were reported.

This is a preview of subscription content, log in to check access.


  1. 1.

    Korenman SG. New insights into erectile dysfunction: a practical approach.Am J Med. 1998; 105:135–144.

  2. 2.

    Virag R, Beck-Archily L. Nosology, epidemiology, clinical quantification of erectile dysfunction.Rev Med Int. 1997;1:10–13.

  3. 3.

    Goldmeier D, Keane FE, Carter P, Hessman A, Harris JRW, Renton A. Prevalence of sexual dysfunction in heterosexual patients attending a central London genitourinary medicine clinic.Int J STD AIDS. 1997;8:303–306.

  4. 4.

    Read S, King M, Watson J. Sexual dysfunction in primary care. Prevalence, characteristics and detection by the general practitioner.J Public Health Med. 1997;19:387–391.

  5. 5.

    Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction.Am J Cardiol. 2000;86:41–45.

  6. 6.

    Keene LC, Davies PH. Drug-related erectile dysfunction.Adverse Drug React Toxicol Rev. 1999; 18:5–24.

  7. 7.

    Waldinger MD, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations.Int Clin Psychopharmacol. 1998;13:27–33.

  8. 8.

    Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?Urology. 2000;56:302–306.

  9. 9.

    Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction.J Urol. 1999;161:5–11.

  10. 10.

    Levy A, Crowley T, Gingell C. Non-surgical management of erectile dysfunction.Clin Endocrinol. 2000;52:263–270.

  11. 11.

    McPhee SJ, Lingappa VR, Ganong WF, Lange JD.Pathophysiology of Disease: An Introduction to Clinical Medicine. 3rd ed. Los Altos, Calif: Lange Medical Books; 2000.

  12. 12.

    Psychorembel. In:Klinisches Wörterbuch. 258th ed. Hilderbrandt H, ed. Berlin: Walter de Gruyter; 1998.

  13. 13.

    Araujo AB, Johannes CB, Feldman HA, Derby CA, McKinlay JB. Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study.Am J Epidemiol. 2000;152:533–541.

  14. 14.

    Manning M, Spahn M, Jünemann K-P. Gefäßflchirurgie, Implantationschirurgie und Vakuumerektionshilfe.Urologie A. 1998;37:509–515.

  15. 15.

    Khan MA, Thompson CS, Sullivan ME, Jeremy JY, Mikhailidis DP, Morgan RJ. The role of prostaglandins in the aetiology and treatment of erectile dysfunction.Prostaglandins Leukot Essent Fatty Acids. 1999;60:169–174.

  16. 16.

    Rutherford D, Duffy FJR, Current treatment of impotence: Viagra and other options.Br J Nurs. 1999;8:235–241.

  17. 17.

    Weig W. Die Rolle von Psychiatrie und Psychotherapie in der Sexualmedizin nach der Markteinführung von Viagra®.Nervenarzt. 2000;71:218–221.

  18. 18.

    Jeunemann K, Alken P. Pharmacology of erectile dysfunction: a review.Int J Impot Res. 1989; 1:71–93.

  19. 19.

    Akimov G, Ponizowski V. Effects of alternating field on healing of ulcers of the lower extremities.Vestn Chir. 1977;119:84–85.

  20. 20.

    Basset C, Pilla AA, Mitchell SN, Pawluk RJ. Nonoperative treatment of pseudoarthroses and nonunions by pulsing electromagnetic fields.Orthop Trans J Bone Joint Surg. 1978;2:218.

  21. 21.

    Bergsmann O. Selektive Feldtherapie bei pseudoradikulären Symptomen. In:Manuelle Medizin, XXI. Vienna, Austria; 1983.

  22. 22.

    Cameron H, Park YS. An examination of the effects of pulsed magnetic fields on knee swelling following total knee replacement. Presented at the International Congress on Foot and Hand Surgery; 1981; São Paulo, Brazil.

  23. 23.

    Ehrmann W, von Leitner H, Ludwig W. Therapie mit ELF-Magnetfeldern.Z Phys Med. 1976; 4:161–170.

  24. 24.

    Evertz U, König H. Pulsierende magnetische Felder in ihrer Bedeutung für die Medizin.Hippokrates. 1977;1:16.

  25. 25.

    Shafik A. Effect of magnetic stimulation on the contractile activity of the rectum in dog.Eur Surg Res. 1998;30:268–272.

  26. 26.

    Shafik A, el-Sibai O. Effect of magnetic stimulation on the contractile activity of the rectum in humans.Am Surg. 2000;66:491–494.

  27. 27.

    Shafik A. Magnetic stimulation: a novel method for the treatment of chronic constipation.Minim Invasive Ther Allied Technol. 1998;7:477–481.

  28. 28.

    Shafik A. Penile erection in dogs by magnetic stimulation of the cavernous nerve.Arch Androl. 1999;43:247–252.

  29. 29.

    Shafik A, el-Sibai O, Shafik AA. Magnetic stimulation of the cavernous nerve for the treatment of erectile dysfunction in humans.Int J Impot Res. 2000;12:137–142.

  30. 30.

    Hainovici N, Negoesen J. Beeinflussung der Kallusbildung unter der Behandlung mit niederfrequenten gepulsten Magnetfeldern.Therapiewoche. 1987;30:4619–4631.

  31. 31.

    Pelka RB, de Moliere M.Migräne, Wetterfühligkeit und Spannungskopfschmerz: Essentielle Linderung durch Magnetwechselfelder? Notabene Medici; 1989.

  32. 32.

    Watson J, Downes E. Clinical aspects of the stimulation of bone healing using electrical phaenomena.Med Biol Eng Comput. 1979;17:261.

  33. 33.

    Tan HL. Economic costs of male erectile dysfunction using a decision analytic model.Pharmacoeconomics. 2000;17:77–107.

  34. 34.

    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors.JAMA. 1999;281:537–544.

Download references

Author information

Correspondence to Rainer B. Pelka Ph.D..

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pelka, R.B., Jaenicke, C. & Gruenwald, J. Impulse magnetic-field therapy for erectile dysfunction: A double-blind, placebo-controlled study. Adv Therapy 19, 53 (2002). https://doi.org/10.1007/BF02850018

Download citation


  • erectile dysfunction
  • magnetic waves
  • alternative therapy
  • impulse magnetic-field therapy